T cells survey the stability of the self: A testable hypothesis on the homeostatic role of TCR-MHC interactions

International Archives of Allergy and Immunology

Volumn 144, Issue 2, 2007, Pages 171-182

  Bakács, Tibor ^a,b   Mehrishi, Jitendra N ^c,g   Szabados, Tamás ^d   Varga, László ^e   Szabó, Miklós ^f   Tusnády, Gábor ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b Cambridge Chronic Hepatitis AIDS New Treatment Strategy Development Initiative   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^e EON Kernkraft GmbH   (Germany)

^f Institute of Isotopes   (Hungary)

^g Cambridge Chronic Hepatitis AIDS New Treatment Strategy Development Initiative   (United Kingdom)

Author keywords

Homeostasis; Immunity, acquired; Immunity, innate; Mutations; TCR MHC interactions

Indexed keywords

CYTOKINE; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR; YELLOW FEVER VACCINE;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE ACTIVATION; CELL DIVISION; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; FOREIGN BODY; GENOME; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFLUENZA; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR EVOLUTION; MOLECULE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTIBODY FORMATION; B-LYMPHOCYTES; EVOLUTION, MOLECULAR; HOMEOSTASIS; HUMANS; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS; PHAGOCYTES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 34548662179     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103282     Document Type: Review

References (104)

1. Porcelli SA: Bird genes give new insights into the origins of lipid antigen presentation. Proc Natl Acad Sci USA 2005;102:8399-8400.
2. Cohn M: The common sense of the self-nonself discrimination. Springer Semin Immunopathol 2005;27:3-17.
3. Bretscher P, Cohn M: A theory of self-nonself discrimination. Science 1970;169:1042-1049.
4. Janeway CA Jr, Travers P, Walport M, Shlomchik MJ: Immunobiology, ed 5. New York, Garland Publishing, 2001.
5. Cohn M, Langman RE: The protection: the unit of humoral immunity selected by evolution. Immunol Rev 1990;115:11-147.
6. Adams D: How the immune system works and why it causes autoimmune diseases. Immunol Today 1996;17:300-302.
7. Langman RE: Molecular economy and antibody function: the evolution of a Protecton. Int J Clin Lab Res 1992;22:63-68.
8. Miller MJ, Wei SH, Cahalan MD, Parker I: Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci USA 2003;100:2604-2609.
9. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK: Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998;281:96-99.
10. Jacob J, Kassir R, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med 1991;173:1165-1175.
11. Yewdell JW, Reits E, Neefjes J: Making sense of mass destruction: quantitating MHC class I antigen presentation: Nat Rev Immunol 2003;3:952-961.
12. Yewdell JW, Bennink JR: Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999;17:51-88.
13. Guidotti LG, Chisari FV: To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996;8:478-483.
14. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-1406.
15. World Health Organization Report on Infectious Diseases 2000. 2000. http://www.who.int/infectious-disease-report/2000/.
16. Crimmins EM, Finch CE: Infection, inflammation, height, and longevity. Proc Natl Acad Sci USA 2006;103:498-503.
17. Ryan KJ, Champoux JJ, Falkow S, Plorde JJ, Drew WL, Neidhardt FC, et al: Sherris Medical Microbiology: An Introduction to Infectious Diseases, ed 3. London, Prentice-Hall International, 1994.
18. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
19. Podolsky SH, Tauber AI: The Generation of Diversity. Cambridge, Harvard University Press, 1997.
20. Burnet FM: A certain symmetry: histocompatibility antigens compared with immunocyte receptors: Nature 1970;226:123-126.
21. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P: Molecular Biology of the Cell, ed 4. New York, Garland Publishing, 2002.
22. Shanker A: Is thymus redundant after adulthood? Immunol Lett 2004;91:79-86.
23. Buell JF, Gross TG, Woodle ES: Malignancy after transplantation. Transplantation 2005;80:S254-S264.
24. Cunliffe J: Tissue homeostasis and immunity - more on models. Scand J Immunol 2006;64:172-176.
25. Foote J, Eisen HN: Breaking the affinity ceiling for antibodies and T cell receptors. Proc Natl Acad Sci USA 2000;97:10679-10681.
26. Kersh GJ, Allen PM. Essential flexibility in the T-cell recognition of antigen. Nature 1996;380:495-498.
27. Kersh GJ, Kersh EN, Fremont DH, Allen PM: High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 1998;9:817-826.
28. Foote J, Eisen HN: Kinetic and affinity limits on antibodies produced during immune responses. Proc Natl Acad Sci USA 1995;92:1254-1256.
29. + T cells without selection of higher affinity TCR. Nat Immunol 2001;2:711-717.
30. Jerne NK: The somatic generation of immune recognition. Eur J Immunol 1971;1:1-9.
31. Kim HJ, Guo D, Sant'Angelo DB: Coevolution of TCR-MHC interactions: conserved MHC tertiary structure is not sufficient for interactions with the TCR. Proc Natl Acad Sci USA 2005;102:7263-7267.
32. Cooper MD, Alder MN: The evolution of adaptive immune systems. Cell 2006;124:815-822.
33. Eggleton P, Crawford N, Fisher D: Fractionation of human neutrophils into subpopulations by countercurrent distribution: surface charge and functional heterogeneity. Eur J Cell Biol 1992;57:265-272.
34. Puellmann K, Kaminski WE, Vogel M, Nebe CT, Schroeder J, Wolf H, et al: A variable immunoreceptor in a subpopulation of human neutrophils. Proc Natl Acad Sci USA 2006;103:14441-14446.
35. Jerne NK: Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C:373-389.
36. Bakács T, Mehrishi JN, Szabados T, Varga L, Tusnády G: Some aspects of complementarity in the immune system: a bird's eye view. Int Arch Allergy Immunol 2001;126:23-31.
37. Root-Bernstein RS, Dillon PF: Molecular complementarity I: the complementarity theory of the origin and evolution of life. J Theor Biol 1997;188:447-479.
38. Dillon PF, Root-Bernstein RS: Molecular complementarity II: energetic and vectorial basis of biological homeostasis and its implications for death. J Theor Biol 1997;188:481-493.
39. Freitas AA, Rocha B: Population biology of lymphocytes: the flight for survival. Annu Rev Immunol 2000;18:83-111.
40. Kirberg J, Berns A, von Boehmer H: Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997;186:1269-1275.
41. Matzinger P: The danger model: a renewed sense of self. Science 2002;296:301-305.
42. Moses CT, Thorstenson KM, Jameson SC, Khoruts A: Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci USA 2003;100:1185-1190.
43. Zinkernagel RM, Hengartner H: On immunity against infections and vaccines: credo 2004. Scand J Immunol 2004;60:9-13.
44. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al: Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004;101:9309-9314.
45. Thompson CJ, Docherty JJ, Boltz RC, Gaines RA, Todd P: Electrokinetic alteration of the surface of herpes simplex virus infected cells. J Gen Virol 1978;39:449-461.
46. Renard V, Cambiaggi A, Vely F, Blery M, Olcese L, Olivero S, et al: Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev 1997;155: 205-221.
47. Ronchese F, Hausmann B: B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J Exp Med 1993;177:679-690.
48. Lafferty KJ, Cunningham AJ: A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci 1975;53: 27-42.
49. Janeway CA Jr: The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11-16.
50. Davis CP, Woods G, Niesel D: Introduction to bacteriology;in Baron S (ed): Medical Microbiology, ed 4. Galveston, The University of Texas Medical Branch at Galveston, 1996.
51. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, et al: The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci USA 2005;102:9577-9682.
52. Conlan JW: Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes , Salmonella typhimurium , and Yersinia enterocolitica. Infect Immun 1997;65:630-635.
53. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H: Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 1994;152:1836-1846.
54. Rogers HW, Unanue ER: Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 1993;61:5090-5096.
55. Wallerstein RO: Blood;in Krupp MA, Chatton MJ, Tierney LM Jr (eds): Current Medical Diagnosis and Treatment 1986. Los Altos, Lange Medical Publications, 1986, pp 340-341.
56. Lathem WW, Crosby SD, Miller VL, Goldman WE: Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity: Proc Natl Acad Sci USA 2005;102:17786-17791.
57. Marketon MM, Depaolo RW, Debord KL, Jabri B, Schneewind O: Plague bacteria target immune cells during infection. Science 2005;309:1739-1741.
58. Yoo JY, Desiderio S: Innate and acquired immunity intersect in a global view of the acute-phase response. Proc Natl Acad Sci USA 2003;100:1157-1162.
59. Paul WE: Fundamental Immunology, ed 4. Philadelphia, Lippincott-Raven Publishers, 1999.
60. Liston A, Gray DH, Lesage S, Fletcher AL, Wilson J, Webster KE, et al: Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med 2004;200:1015-1026.
61. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996;272:60-86.
62. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999;189:331-339.
63. Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C: Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci USA 2005;102:17729-17733.
64. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, et al: Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003;33:125-134.
65. Smith MA, Naziruddin B, Poindexter NJ, Haynes AE, Howard T, Mohanakumar T: Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis: Transplantation 2000;69:157-162.
66. Ishizaka S, Tsujii T: Soluble T-cell products antigenically related to T-cell receptors. Cytokine 1995;7: 260-266.
67. Cebecauer M, Guillaume P, Hozak P, Mark S, Everett H, Schneider P, et al: Soluble MHC-peptide complexes induce rapid death of CD8+ CTL. J Immunol 2005;174:6809-6819.
68. Coles RM, Jones CM, Brooks AG, Cameron PU, Heath WR, Carbone FR: Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes. Eur J Immunol 2003;33:1557-1567.
69. den Dulk M, Bishop GA: Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation. Arch Immunol Ther Exp (Warsz) 2003;51: 29-44.
70. Jinushi M, Hodi FS, Dranoff G: Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity. Proc Natl Acad Sci USA 2006;103:9190-9195.
71. Jones SA, Rose-John S: The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta 2002;1592: 251-263.
72. Sykulev Y, Cohen RJ, Eisen HN: The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1995;92:11990-11992.
73. Verbruggen LA, Dumarey N, Van de Velde H, Rebmann V, Flament J, Van Wayenberge C, et al: Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens 2000;56:436-440.
74. Matsui K, Boniface JJ, Steffner P, Reay PA, Davis MM: Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994;91:12862-12866.
75. Feinberg MB: Changing the natural history of HIV disease. Lancet 1996;348: 239-246.
76. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60-66.
77. Francavilla A, Zeng Q, Polimeno L, Carr BI, Sun D, Porter KA, et al: Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology 1994;19:210-216.
78. Van Thiel DH, Gavaler JS, Kam I, Francavilla A, Polimeno L, Schade RR, et al: Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology 1987;93:1414-1419.
79. Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, Marino IR, et al: Baboon-to-human liver transplantation. Lancet 1993;341:65-71.
80. Martinez-Hernandez A, Amenta PS: The extracellular matrix in hepatic regeneration. FASEB J 1995;9:1401-1410.
81. Peters M, Blinn G, Jostock T, Schirmacher P, Meyer zum Buschenfelde KH, Galle PR, et al: Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 2000;119:1663-1671.
82. Burroughs NJ, de Boer RJ, Kesmir C: Discriminating self from nonself with short peptides from large proteomes. Immunogenetics 2004;56:311-320.
83. Altan-Bonnet G, Germain RN: Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biol 2005;3:e356.
84. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN: Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996;4:565-571.
85. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-179.
86. Subbarao K, Murphy BR, Fauci AS: Development of effective vaccines against pandemic influenza. Immunity 2006;24:5-9.
87. Poland GA: Vaccines against avian influenza - a race against time. N Engl J Med 2006;354:1411-1413.
88. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al: Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006;355:1018-1028.
89. Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, et al: Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 2005;202:445-455.
90. Marshall E: Drug trials: violent reaction to monoclonal antibody therapy remains a mystery. Science 2006;311:1688-1689.
91. Hünig T, Dennehy K: CD28 superagonists: mode of action and therapeutic potential. Immunol Lett 2005;100: 21-28.
92. Mehrishi JN, SzabóM, Bakács T: Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials. Vaccine 2007;25:3517-3523.
93. Hjelm F, Carlsson F, Getahun A, Heyman B: Antibody-mediated regulation of the immune response. Scand J Immunol 2006;64:177-184.
94. Lespagnard L, Mettens P, De Smedt T, Bazin H, Urbain J, Leo O, et al: The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance. Int Immunol 1998;10: 295-304.
95. Margulies DH: CD28, costimulator or agonist receptor? J Exp Med 2003;197:949-953.
96. Travis K: Deciphering immunology's dirty little secret. Can toll-like receptor targeted immune adjuvants save vaccinology? The Scientist 2007;21:46. http://www.the-scientist.com/toc/2007/1/1/.
97. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, et al: Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006;203:413-424.
98. Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H, et al: Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 2000;31:907-915.
99. Laudanski K, Miller-Graziano C, Xiao W, Mindrinos MN, Richards DR, De A, et al: Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci USA 2006;103:15564-15569.
100. Strey CW, Winters MS, Markiewski MM, Lambris JD: Partial hepatectomy induced liver proteome changes in mice. Proteomics 2005;5:318-325.
101. Guo F, Nian H, Zhang H, Huang L, Tang Y, Xiao X, et al: Proteomic analysis of the transition from quiescent to proliferating stages in rat liver hepatectomy model. Proteomics 2006;6:3075-3086.
102. Anisimov VN, Zabezhinski MA, Rossolini G, Zaia A, Piantanelli A, Basso A, et al: Long-live euthymic BALB/c-nu mice. II. Spontaneous tumors and other pathologies. Mech Ageing Dev 2001;122:477-489.
103. Vessey CJ, Norbury CJ, Hickson ID: Genetic disorders associated with cancer predisposition and genomic instability. Prog Nucleic Acid Res Mol Biol 1999;63:189-221.
104. German J: Bloom's syndrome. Dermatol Clin 1995;13:7-18.